Summary
This prediction ended on 11.02.13 with a price of €114.09. With a performance of 6.51%, the BUY prediction by melinda for Endologix closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Endologix | - | - | - | - |
| iShares Core DAX® | -1.742% | -10.677% | -0.889% | 48.094% |
| iShares Nasdaq 100 | -2.583% | -3.319% | 11.124% | 74.134% |
| iShares Nikkei 225® | -1.165% | -9.362% | 23.687% | 48.880% |
| iShares S&P 500 | -1.422% | -3.762% | 7.187% | 57.428% |
Comments by melinda for this prediction
In the thread Endologix diskutieren
Transplantations-Chirurgie
endololix entwickelt, vermarktet und vertreibt Behandlungen für Aorten-Erkrankungen produziert seine Powerlink (Katheter)
(Laufzeit überschritten)